Aligos Therapeutics Inc (ALGS) — Cash Flow Quality Index

Latest as of March 2025: -0.49x

Aligos Therapeutics Inc (ALGS) has a Cash Flow Quality Index of -0.49x as of March 2025. Operating cash flow of $-20.91 Million is below net income of $43.09 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ALGS long-term investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.49x
Operating CF / Net Income

Operating Cash Flow

$-20.91 Million
USD

Net Income

$43.09 Million
USD

Data as of

Mar 2025
Most recent filing

Annual Cash Flow Quality Index for Aligos Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Aligos Therapeutics Inc. For live market cap and the full company financial profile, see market value of Aligos Therapeutics Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.